The Center for Quantitative Methods and Data Sciences, in partnership with the Biostatistics, Epidemiology and Research Design (BERD) Center and the Data-Intensive Studies Center (DISC) will host a Zoom seminar series on a Wednesday each month from 2:00-3:00PM.

The October session on Wednesday, October 21 will feature Cody Meissner, MD, and Norma Terrin, PhD. They will speak about the promise of COVID-19 vaccines in controlling the pandemic.


The discussion will cover approaches to SARS-CoV-2 vaccine development; emergency use authorization (EUA) vs. biologic license application (BLA); acceptable safety and effectiveness; unanticipated serious adverse reactions that occurred following introduction of previous vaccines; and vaccine trial sample size justification.


Dr. Meissner is Professor of Pediatrics at Tufts University School of Medicine and Head of the Pediatric Infectious Disease Service at Tufts Medical Center. He is a Consultant to the Committee on Infectious Disease and an Associate Editor of the Red Book for the American Academy of Pediatrics. He has served as a member of the Advisory Committee on Infectious Diseases (ACIP) at the Centers for Disease Control and Prevention (CDC) and continues to advise CDC Work Groups. He presently serves as a member of the National vaccine Advisory Committee (NVAC) and as a member of the Vaccines and Related Biologic Products Advisory Committee (VRBPAC) for the Food and Drug Administration. He serves as a member of the Massachusetts Vaccine Purchasing Council. He has published over 250 papers on various aspects of infectious disease.

Dr. Terrin is the Scientific Director of the BERD Center at Tufts Clinical and Translational Science Institute (CTSI) and Professor at Tufts University School of Medicine. She has collaborated with clinical investigators, including infectious disease researchers, throughout her career, and she served as Statistics Editor at Clinical Infectious Diseases for 12 years.


Date: Wednesday, October 21, 2020, 2:00-3:00PM

Location: Zoom video conference. \